# CEREBAIN BIOTECH CORP.

CEREBAIN BIOTECH CORP. is a company headquartered in Costa Mesa, CA, United States.

## Company overview

- **Legal name:** CEREBAIN BIOTECH CORP.
- **Former names in filing history:** DISCOUNT DENTAL MATERIALS, INC. (2009-01-27 to 2014-06-11)
- **Classification:** Company
- **Industry (SIC):** 5047 — Wholesale-Medical, Dental & Hospital Equipment & Supplies
- **Headquarters:** Costa Mesa, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** June 30
- **SEC CIK:** 0001453099

## About

CEREBAIN BIOTECH CORP. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001453099, and its reported industry is Wholesale-Medical, Dental & Hospital Equipment & Supplies. In 10-K filed on 2018-09-26, it reported net income of USD -4,918,792; total assets of USD 91,601 for the fiscal period ended 2018-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-06-30)

- **Net income:** -$4.9M (USD -4,918,792)
- **Total assets:** $91,601 (USD 91,601)
- **Cash and equivalents:** $64,583 (USD 64,583)
- **Operating cash flow:** -$750,012 (USD -750,012)

### FY2017 (period ended 2017-06-30)

- **Net income:** -$16.0M (USD -16,012,615)
- **Total assets:** $236,862 (USD 236,862)
- **Cash and equivalents:** $11,345 (USD 11,345)
- **Operating cash flow:** -$664,900 (USD -664,900)

### FY2016 (period ended 2016-06-30)

- **Net income:** -$2.4M (USD -2,423,661)
- **Total assets:** $495,944 (USD 495,944)
- **Cash and equivalents:** $20,245 (USD 20,245)
- **Operating cash flow:** -$564,953 (USD -564,953)

### FY2015 (period ended 2015-06-30)

- **Net income:** -$2.9M (USD -2,939,717)
- **Total assets:** $369,613 (USD 369,613)
- **Cash and equivalents:** $486 (USD 486)
- **Operating cash flow:** -$710,752 (USD -710,752)

## Recent SEC filings

- Form 8-K — filed 2019-07-23 — period 2019-07-01 — FORM 8-K
- Form 10-Q — filed 2019-05-20 — period 2019-03-31 — FORM 10-Q
- Form 8-K — filed 2019-04-05 — period 2019-03-01 — FORM 8-K
- Form 10-Q — filed 2019-02-19 — period 2018-12-31 — FORM 10-Q
- Form SC 13G — filed 2019-02-15 — SCHEDULE 13G
- Form 8-K — filed 2018-12-26 — period 2018-12-10 — FORM 8-K
- Form 10-Q — filed 2018-11-14 — period 2018-09-30 — FORM 10-Q
- Form 10-K — filed 2018-09-26 — period 2018-06-30 — FORM 10-K
- Form 10-Q — filed 2018-05-15 — period 2018-03-31 — FORM 10-Q
- Form 8-K — filed 2018-03-13 — period 2018-03-02 — FORM 8-K
- Form 10-Q — filed 2018-02-06 — period 2017-12-31 — FORM 10-Q
- Form 10-Q — filed 2017-11-09 — period 2017-09-30 — FORM 10-Q

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/cerebain-biotech-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology